Institute of Metabolic Disease, Baylor Healthcare

Dallas, Texas 75226

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Fabry Disease Clinical Trial
Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function
Status: Enrolling, Phase III
Updated: 12/31/1969
Institute of Metabolic Disease, Baylor Healthcare
mi
from
Dallas, TX
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Extension Study of 1 mg/kg Pegunigalsidase Alfa in Patients With Fabry Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Institute of Metabolic Disease, Baylor Healthcare
mi
from
Dallas, TX
Click here to add this to my saved trials